Industry Reports |
Pharmaceuticals & Healthcare |
| No. |
Report Title |
Page |
Single User Price |
32 |
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs |
76 |
168000 |
Buy |
| 33 |
The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis |
102 |
168000 |
Buy |
34 |
The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis |
75 |
168000 |
Buy |
35 |
The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis |
101 |
168000 |
Buy |
36 |
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges |
141 |
168000 |
Buy |
37 |
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues |
165 |
168000 |
Buy |
| 38 |
The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities |
145 |
168000 |
Buy |
39 |
Osteoarthritis - Drug Pipeline Analysis and Market Forecasts to 2016 |
40 |
96000 |
Buy |
40 |
Macular Degeneration - Drug Pipeline Analysis and Market Forecasts to 2016 |
48 |
96000 |
Buy |
41 |
Benign Prostatic Hyperplasia - Drug Pipeline Analysis and Market Forecasts to 2016 |
47 |
96000 |
Buy |
42 |
Women’s Infertility - Drug Pipeline Analysis and Market Forecasts to 2016 |
31 |
96000 |
Buy |
| 43 |
Urinary Incontinence (UI) - Drug Pipeline Analysis and Market Forecasts to 2016 |
42 |
96000 |
Buy |
| 44 |
Erectile Dysfunction - Drug Pipeline Analysis and Market Forecasts to 2016 |
37 |
96000 |
Buy |
| 45 |
Tuberculosis - Drug Pipeline Analysis and Market Forecasts to 2016 |
44 |
96000 |
Buy |
| 46 |
Hepatitis B - Drug Pipeline Analysis and Market Forecasts to 2016 |
36 |
96000 |
Buy |
| 47 |
Candidiasis - Drug Pipeline Analysis and Market Forecasts to 2016 |
44 |
96000 |
Buy |
| 48 |
Acne - Drug Pipeline Analysis and Market Forecasts to 2016 |
49 |
96000 |
Buy |
| 49 |
Dysmenorrhea - Drug Pipeline Analysis and Market Forecasts to 2016 |
40 |
96000 |
Buy |
| 50 |
Anemia - Drug Pipeline Analysis and Market Forecasts to 2016 |
58 |
96000 |
Buy |
| 51 |
Herpes Simplex - Drug Pipeline Analysis and Market Forecasts to 2016 |
37 |
96000 |
Buy |
| 52 |
Stomach Cancer - Drug Pipeline Analysis and Market Forecasts to 2016 |
44 |
96000 |
Buy |
| 53 |
Hepatitis C (HCV) – Pipeline Assessment and Market Forecasts to 2016 |
60 |
96000 |
Buy |
| 54 |
Pneumonia - Drug Pipeline Analysis and Market Forecasts to 2016 |
47 |
96000 |
Buy |
| 55 |
Hemophilia - Drug Pipeline Analysis and Market Forecasts to 2016 |
32 |
96000 |
Buy |
| 56 |
Allergic Conjunctivitis - Drug Pipeline Analysis and Market Forecasts to 2016 |
39 |
96000 |
Buy |
| 57 |
Bronchitis - Drug Pipeline Analysis and Market Forecasts to 2016 |
37 |
96000 |
Buy |
| 58 |
Pancreatic Cancer - Drug Pipeline Analysis and Market Forecasts to 2016 |
41 |
96000 |
Buy |
| 59 |
Neutropenia - Drug Pipeline Analysis and Market Forecasts to 2016 |
39 |
96000 |
Buy |
60 |
Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016 |
41 |
96000 |
Buy |
| 61 |
Pharmaceutical Research and Development (R&D) - Increasing Efficiency through Information Technology and Externalization |
82 |
168000 |
Buy |
| 62 |
The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets |
138 |
168000 |
Buy |
|
